DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $78,345,000 | -18.9% | 3,886,181 | +50.1% | 0.00% | -20.0% |
Q2 2021 | $96,624,000 | +24.1% | 2,589,062 | -15.0% | 0.01% | +25.0% |
Q1 2021 | $77,875,000 | +25.3% | 3,045,557 | +8.0% | 0.00% | 0.0% |
Q4 2020 | $62,127,000 | +10.0% | 2,820,099 | -10.2% | 0.00% | 0.0% |
Q3 2020 | $56,477,000 | -22.5% | 3,139,373 | +9.5% | 0.00% | -20.0% |
Q2 2020 | $72,827,000 | +135.5% | 2,867,195 | +70.4% | 0.01% | +66.7% |
Q1 2020 | $30,918,000 | -15.4% | 1,683,085 | +1.5% | 0.00% | 0.0% |
Q4 2019 | $36,532,000 | +42.7% | 1,658,270 | -7.0% | 0.00% | +50.0% |
Q3 2019 | $25,603,000 | -9.5% | 1,782,945 | -0.7% | 0.00% | 0.0% |
Q2 2019 | $28,284,000 | +2.6% | 1,795,778 | -4.6% | 0.00% | 0.0% |
Q1 2019 | $27,565,000 | +26.1% | 1,881,583 | -8.0% | 0.00% | 0.0% |
Q4 2018 | $21,860,000 | +79.6% | 2,044,890 | +156.3% | 0.00% | +100.0% |
Q3 2018 | $12,173,000 | +34.4% | 797,703 | +7.9% | 0.00% | 0.0% |
Q2 2018 | $9,059,000 | +4094.0% | 739,452 | +3174.4% | 0.00% | – |
Q1 2018 | $216,000 | +129.8% | 22,583 | +118.8% | 0.00% | – |
Q4 2017 | $94,000 | -91.6% | 10,321 | -95.1% | 0.00% | – |
Q1 2016 | $1,123,000 | -45.4% | 209,015 | +20.7% | 0.00% | – |
Q4 2015 | $2,056,000 | +75.4% | 173,195 | +21.3% | 0.00% | – |
Q3 2015 | $1,172,000 | -33.8% | 142,741 | +12.4% | 0.00% | – |
Q2 2015 | $1,771,000 | +28.4% | 126,945 | +120.7% | 0.00% | – |
Q1 2015 | $1,379,000 | +31.8% | 57,511 | -9.5% | 0.00% | – |
Q4 2014 | $1,046,000 | +20.2% | 63,562 | -6.9% | 0.00% | – |
Q3 2014 | $870,000 | -39.3% | 68,281 | +7.6% | 0.00% | – |
Q2 2014 | $1,433,000 | +77.1% | 63,452 | +121.5% | 0.00% | – |
Q1 2014 | $809,000 | – | 28,645 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|